Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Animal Healthcare Market Outlook

The animal healthcare market size is projected to be valued at US$ 40.9 billion in 2023 and is expected to rise to US$ 62.3 billion by 2033. The sales of animal healthcare are expected to grow at a significant CAGR of 4.3% during the forecast period. Various factors propelling the demand for animal healthcare are:

Animal health monitoring and disease outbreak prevention are critical to the economy and the safety of the country's food supply. Healthy livestock production contributes to a secure food supply and stable consumer prices.

The emphasis on animal health ensures that healthcare researchers and practitioners in both fields collaborate to prevent disease outbreaks across species and address the underlying cause of their spread.

This has resulted in the successful management of deadly diseases such as avian flu and is now being used to eradicate others in the future.

Recent years have seen significant mergers and acquisitions between major companies' veterinary-related divisions, as well as rising demands for food and feed and the production of animals bred for meat and dairy products.

A vast proportion of investing in pet insurance in developed markets is driving growth in the market under consideration. However, that investment is being used to fund animal health innovations for the world's 24 billion chickens, 1 billion cattle and sheep, 750 million pigs and goats, 500 million dogs, and 400 million cats.

At the moment, the animal healthcare market is benefiting greatly from initiatives spearheaded by governments and animal welfare organizations from around the world.

Technological advancements in animal healthcare are also driving the global market, which is expected to provide future growth opportunities.

Among these breakthroughs is the creation of efficient information management systems, mobile technologies for animal owners, and vaccine banks. The increased emphasis on animal health innovation has resulted in a number of measures that are improving market growth prospects.

Attributes Details
Animal Healthcare Market CAGR 4.3%
Animal Healthcare Market Valuation (2023) US$ 40.9 billion
Animal Healthcare Market Valuation (2033) US$ 62.3 billion

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Market Dynamics

Growing Demand for Animal Products and Increasing Incidence of Animal Diseases Spurring Market Growth

The primary factors fueling demand in the animal healthcare market are the increasing consumption of meat and milk globally, the rising prevalence of foodborne and zoonotic diseases, the growing trend of pet adoption across the world, and the exponential growth of the veterinary healthcare market.

Over the last few decades, spending on animals has increased significantly on account of rising pet adoption rates, growing awareness about maintaining the proper health of animals, and surging demand for animal pharmaceuticals for enhancing the immunity system of animals. Driven by this, sales of animal healthcare products like pharmaceuticals, animal feeds, and vaccines are projected to rise at a significant pace during the forecast period.

On the other hand, factors hampering the growth of the animal healthcare market are increasing restrictions imposed by regulatory authorities on the usage of antibiotics, lack of awareness across various emerging regions, and rising cost of animal testing.

Past vs Future Market Performance

Over the last few years, veterinary healthcare has rapidly evolved as technology in biotech, genomics, artificial intelligence, cloud computing, and big data has grown exponentially, bringing competition among large animal healthcare companies and collaborations with technologically advanced start-ups. In addition, significant mergers and acquisitions have occurred in the industry in recent years, such as that between Boehringer Ingelheim Animal Health and Merial. As a result, the veterinary healthcare market has become extremely competitive.

Vaccines have become increasingly important in various parts of the world. Across major consumer spending stores worldwide, a large number of families have chosen pet insurance. In several cases involving food-producing animals, the industry and governments collaborate to develop vaccines against major outbreaks of animal diseases such as foot-and-mouth disease. The lack of vaccines against several livestock vector-borne pathogens, as well as strict regulatory approval processes for gaining market authorization, are two major market challenges. Vaccine bank funding has grown in importance over time. Vaccines' necessity and development are expected to drive the growth of the veterinary healthcare market over the forecast period.

Considering this, FMI expects global animal healthcare to grow at a CAGR of 4.3% through 2033.

The adoption of digital technology in livestock and pet health is increasing at an alarming rate. Smart tags, wearables, and sound detection tools, as well as predictive software and monitoring technology, enable precision care for thousands of animals. Data from countless animals are being compiled by digital diagnostics in order to discover new, subtle disease warning signs. Better traceability, sustainability, productivity, and disease management on the farm are all advantages, as is improved pet wellness.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative view of Animal Healthcare Market

Animal Healthcare Market:

Attributes Animal Healthcare Market
CAGR (2022 to 2032) 4.3%
Market Value (2026) US$ 24.28 billion
Growth Factor The market is primarily driven by an increase in protein food demand and a rise in the prevalence of zoonotic and food-borne diseases worldwide.
Opportunity The rapid increase in sales of animal healthcare products such as pharmaceuticals is acting as a catalyst for the growth of the animal healthcare market, and this trend is expected to continue in the future.

Animal Model Market:

Attributes Animal Model Market
CAGR (2022 to 2032) 6.6%
Market Value (2026) US$ 2.2 billion
Growth Factor The market is growing due to the increasing use of animal models in drug development and the rising demand for efficient animal models.
Opportunity The development of a novel monkey research model using CRISPR technology is one of the market's most significant developments which would bring various opportunities.

Animal Feed Additives Market:

Attributes Animal Feed Additives Market
CAGR (2022 to 2032) 2.70%
Market Value (2026) US$ 18.69 billion
Growth Factor Controlling feedstock contamination is expected to result in improved product offerings, leading to market expansion.
Opportunity Product innovations in the market are increasing as there is a greater emphasis on the inclusion of probiotics and proteins in animal feed additives.

Country-wise Analysis

According to FMI, the USA would witness market growth of around US$ 4.7 billion

Animal healthcare is a vital component of the US economy. It is one of the most innovative industries in the US, accounting for 2% of the total USA pharmaceutical market. Each year, Mexico and Canada are among the top export markets for US meat and dairy products. Aside from the economic benefits, the social benefits of animals are extensive and widely recognized by many communities. According to the American Pet Products Association, overall spending on pets in the United States increased by 4.1% between 2016 and 2017, rising from US$ 66.75 billion to US$ 69.51 billion. As a result of several factors assisting in the development of a better environment, the North American region plays an important role in the growth of veterinary healthcare.

Market Size 2033 US$ 15.5 billion
Market Absolute Dollar Growth US$ 4.7 billion
CAGR (2017 to 2022) 3.3%
CAGR % 2023 to End of Forecast (2033) 3.7%

Favorable policies are creating an optimistic environment for the market

The UK animal healthcare market is expected to witness a revenue share of around US$ 2.0 billion, owing to the increasing burden of disease outbreaks among livestock animals. The European Union has launched a number of strategic initiatives to address animal health issues and raise awareness about the importance of animal healthcare. Growing investments in animal healthcare, as well as the presence of major animal health companies, will undoubtedly add to the regional outlook.

Market Size 2033 US$ 2.0 billion
Market Absolute Dollar Growth US$ 509.6 million
CAGR (2017 to 2022) 3.6%
CAGR % 2023 to End of Forecast (2033) 3.1%

The rise in radial artery occlusion is catering to the UK market growth

The UK witnessed a growth of US$ 15.9 million over the last decade and a CAGR of 9.4%. In the United Kingdom, radial access is used for more than 75% of percutaneous coronary intervention (PCI, formerly known as angioplasty with stent). The parallel rise in radial artery occlusion may be contributing to the growing demands for radial compression. Experts also noted a desire to embrace procedures and started trying innovative devices that contribute to better patient experiences, lower medical costs, and shorter hospital stays.

Market Size 2033 US$ 26.7 million
Market Absolute Dollar Growth US$ 15.9 million
CAGR (2017 to 2022) 8.6%
CAGR % 2023 to End of Forecast (2033) 9.4%

Indian Animal Health Industry has played a critical role in protecting the nation's animal husbandry interests

In 2021, the Asia Pacific held the largest share of the Indian animal healthcare market. From 2023 to 2033, the Asia Pacific animal healthcare market is expected to register a revenue share of US$ 2.4 billion. India’s large market share can be attributed to an increase in the number of polyclinics, veterinary hospitals, and institutions, as well as innovative technologies. Increased collaboration with animal healthcare funding trusts and organizations, as well as the positive impact of state government regulations, are expected to propel the market.

Market Size 2033 US$ 2.4 billion
Market Absolute Dollar Growth US$ 1.1 billion
CAGR (2017 to 2022) 7.3%
CAGR % 2023 to End of Forecast (2033) 6.2%

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Animal Healthcare Market - Category-wise Insights

Standardization in animal health is leading parasiticides to a growth of 3.2%

Vaccines and parasiticides have increased from 56.7% to 62.6% of the product portfolio since 2013, while antimicrobials have decreased from 20.9% to 15.2% (a 28% relative decrease), demonstrating a continued push for disease prevention as the foundation for animal health and well-being. The parasiticides segment is driven by the increasing importance of animal healthcare, which is accompanied by governmental protocols. The increased number of animal livestock in emerging markets, developments in parasiticide products, an upcoming new offering by the key players, and the execution of welfare acts in developing and developed regions worldwide are some of the growth drivers of the segment.

Drug Type Parasiticides
CAGR % (2017 to 2022) 4.0%
CAGR % (2023 to 2033) 3.2%

Growing focus on animal healthcare is leading the segment's growth

The animal healthcare market will be greatly benefitted from the farm animal segment. The segment's major market share can be attributed to the deep concern for food safety and sustainability among government healthcare organizations worldwide. Various countries' policymakers are working to achieve maximum food security, which moves large-scale food production and livestock rearing. Long-term sustainability is the goal of the policies, which can be gained by increasing productivity and focusing more attention on livestock animal care.

Animal Type Farm Animals
CAGR % 2017 to 2022 5.1%
CAGR % 2023 to End of Forecast (2033) 4.3%

Manufacturers are focusing on public awareness as their effective market strategy

To gain a competitive advantage, major corporations have implemented a variety of business strategies, including regional expansion strategies, mergers and acquisitions, and collaborative research initiatives. Several programs and initiatives are underway to raise public awareness and education about animal health and well-being. Among the world's leading animal healthcare companies are Neogen, Zoetis, Merck, Boehringer Ingelheim, Elanco, Dechra Pharmaceuticals, IDEXX Laboratories, B. Braun Vet Care, and Medtronic.

  • Cadila Healthcare's (Zydus Cadila's) wholly-owned material subsidiary Zydus Animal Health and Investments (ZAHL), sold its animal healthcare business for nearly INR 3,000 crore to a consortium led by Multiples Alternate Asset Management in May 2021.
  • Hester Biosciences announced in April 2021 that it would begin developing research-based herbal products for poultry, cattle, sheep, goats, and swine.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ billion for Value
Key Countries Covered USA, Canada, Germany, UK, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered
  • Product Type
  • Animal Type
  • Region
Key Companies Profiled Neogen, Zoetis, Merck, Boehringer Ingelheim, Elanco, Dechra Pharmaceuticals, IDEXX Laboratories, B. Braun Vet Care, and Medtronic
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Animal Healthcare Market Segmentation

Product Type:

  • Feed Additives
  • Pharmaceuticals
  • Vaccines

Animal Type:

  • Production Animals
  • Companion Animals

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Frequently Asked Questions

What Big is the Global Animal Healthcare Market Presently?

In 2023, the overall market is estimated to generate a revenue of US$ 40.9 billion.

Which Category Generates the Highest Revenue for the Market?

The vaccines and parasiticides category generates almost 62.6% of the total market.

What Makes the United Kingdom the Leading Region for Global Animal Healthcare Market?

The country is predicted to witness a y-o-y increment of 9.4% over the next ten years.

What is the Share of the United States in the Global Animal Healthcare Market?

The United States market is estimated to have a growth opportunity of US$ 4.7 billion by 2033.

Which Will be the Most Promising Region for Asia Pacific Animal Healthcare Market?

India, with a huge animal farming sector, is poised to witness a CAGR of 6.2% through 2033.

Table of Content

1. Executive Summary | Animal Healthcare Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Drug Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Drug Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Type, 2023 to 2033

        5.3.1. Anti-Infective Agents

            5.3.1.1. Antibiotics & Antimicrobials

            5.3.1.2. Anti-Fungal

            5.3.1.3. Anti-Viral

        5.3.2. Anti-Inflammatory & Analgesic Agents

        5.3.3. Parasiticides

            5.3.3.1. Endo-Parasiticides

            5.3.3.2. Ecto-Parasiticides

            5.3.3.3. Endectocides

        5.3.4. Vaccines

        5.3.5. Hormones & Substitutes

        5.3.6. Nutritional Products

        5.3.7. Others

    5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Drug Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Animal Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033

        6.3.1. Companion Animals

            6.3.1.1. Cats

            6.3.1.2. Dogs

            6.3.1.3. Horse

        6.3.2. Farm Animals

            6.3.2.1. Ruminants

            6.3.2.2. Swine

            6.3.2.3. Poultry

    6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route of Administration

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033

        7.3.1. Oral

            7.3.1.1. Tablets/Capsules

            7.3.1.2. Liquids

            7.3.1.3. Powders/Premix

            7.3.1.4. Others

        7.3.2. Parenteral

            7.3.2.1. Liquids

            7.3.2.2. Powder for Injection

        7.3.3. Topical

            7.3.3.1. Solutions

            7.3.3.2. Creams & Ointments

            7.3.3.3. Intramammary Preparations

            7.3.3.4. Others

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033

        8.3.1. Veterinary Hospitals

        8.3.2. Veterinary Clinics

        8.3.3. Pharmacies & Drug Stores

        8.3.4. Others

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022

    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific

        9.3.5. Middle East & Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Drug Type

        10.2.3. By Animal Type

        10.2.4. By Route of Administration

        10.2.5. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Drug Type

        10.3.3. By Animal Type

        10.3.4. By Route of Administration

        10.3.5. By Distribution Channel

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Argentina

            11.2.1.4. Rest of Latin America

        11.2.2. By Drug Type

        11.2.3. By Animal Type

        11.2.4. By Route of Administration

        11.2.5. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drug Type

        11.3.3. By Animal Type

        11.3.4. By Route of Administration

        11.3.5. By Distribution Channel

    11.4. Key Takeaways

12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. UK

            12.2.1.3. France

            12.2.1.4. Italy

            12.2.1.5. Spain

            12.2.1.6. Russia

            12.2.1.7. Benelux

            12.2.1.8. Nordic Countries

            12.2.1.9. Rest of Europe

        12.2.2. By Drug Type

        12.2.3. By Animal Type

        12.2.4. By Route of Administration

        12.2.5. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drug Type

        12.3.3. By Animal Type

        12.3.4. By Route of Administration

        12.3.5. By Distribution Channel

    12.4. Key Takeaways

13. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Japan

            13.2.1.2. India

            13.2.1.3. China

            13.2.1.4. Australia and New Zealand

            13.2.1.5. Rest of Asia Pacific

        13.2.2. By Drug Type

        13.2.3. By Animal Type

        13.2.4. By Route of Administration

        13.2.5. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drug Type

        13.3.3. By Animal Type

        13.3.4. By Route of Administration

        13.3.5. By Distribution Channel

    13.4. Key Takeaways

14. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Rest of MEA

        14.2.2. By Drug Type

        14.2.3. By Animal Type

        14.2.4. By Route of Administration

        14.2.5. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drug Type

        14.3.3. By Animal Type

        14.3.4. By Route of Administration

        14.3.5. By Distribution Channel

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. US

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Drug Type

            15.1.2.2. By Animal Type

            15.1.2.3. By Route of Administration

            15.1.2.4. By Distribution Channel

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Drug Type

            15.2.2.2. By Animal Type

            15.2.2.3. By Route of Administration

            15.2.2.4. By Distribution Channel

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Drug Type

            15.3.2.2. By Animal Type

            15.3.2.3. By Route of Administration

            15.3.2.4. By Distribution Channel

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Drug Type

            15.4.2.2. By Animal Type

            15.4.2.3. By Route of Administration

            15.4.2.4. By Distribution Channel

    15.5. Argentina

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Drug Type

            15.5.2.2. By Animal Type

            15.5.2.3. By Route of Administration

            15.5.2.4. By Distribution Channel

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Drug Type

            15.6.2.2. By Animal Type

            15.6.2.3. By Route of Administration

            15.6.2.4. By Distribution Channel

    15.7. UK

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Drug Type

            15.7.2.2. By Animal Type

            15.7.2.3. By Route of Administration

            15.7.2.4. By Distribution Channel

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Drug Type

            15.8.2.2. By Animal Type

            15.8.2.3. By Route of Administration

            15.8.2.4. By Distribution Channel

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Drug Type

            15.9.2.2. By Animal Type

            15.9.2.3. By Route of Administration

            15.9.2.4. By Distribution Channel

    15.10. Spain

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Drug Type

            15.10.2.2. By Animal Type

            15.10.2.3. By Route of Administration

            15.10.2.4. By Distribution Channel

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Drug Type

            15.11.2.2. By Animal Type

            15.11.2.3. By Route of Administration

            15.11.2.4. By Distribution Channel

    15.12. Benelux

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Drug Type

            15.12.2.2. By Animal Type

            15.12.2.3. By Route of Administration

            15.12.2.4. By Distribution Channel

    15.13. Nordic Countries

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Drug Type

            15.13.2.2. By Animal Type

            15.13.2.3. By Route of Administration

            15.13.2.4. By Distribution Channel

    15.14. Japan

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Drug Type

            15.14.2.2. By Animal Type

            15.14.2.3. By Route of Administration

            15.14.2.4. By Distribution Channel

    15.15. India

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Drug Type

            15.15.2.2. By Animal Type

            15.15.2.3. By Route of Administration

            15.15.2.4. By Distribution Channel

    15.16. China

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Drug Type

            15.16.2.2. By Animal Type

            15.16.2.3. By Route of Administration

            15.16.2.4. By Distribution Channel

    15.17. ANZ

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Drug Type

            15.17.2.2. By Animal Type

            15.17.2.3. By Route of Administration

            15.17.2.4. By Distribution Channel

    15.18. GCC Countries

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Drug Type

            15.18.2.2. By Animal Type

            15.18.2.3. By Route of Administration

            15.18.2.4. By Distribution Channel

    15.19. South Africa

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Drug Type

            15.19.2.2. By Animal Type

            15.19.2.3. By Route of Administration

            15.19.2.4. By Distribution Channel

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Drug Type

        16.3.3. By Animal Type

        16.3.4. By Route of Administration

        16.3.5. By Distribution Channel

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Bayer AG

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Cargill, Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Eli Lilly and Company

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Boehringer Ingelheim GmbH

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Ceva Sante Animale

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Zoetis Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. Merc & Co., Inc.

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Virbac S.A.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. SeQuent Scientific Ltd.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Midmark Corporation

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Drug Type, 2017 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Animal Type, 2017 to 2033

Table 4: Global Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033

Table 5: Global Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2033

Table 6: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Drug Type, 2017 to 2033

Table 8: North America Market Value (US$ Million) Forecast by Animal Type, 2017 to 2033

Table 9: North America Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033

Table 10: North America Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2033

Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 12: Latin America Market Value (US$ Million) Forecast by Drug Type, 2017 to 2033

Table 13: Latin America Market Value (US$ Million) Forecast by Animal Type, 2017 to 2033

Table 14: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033

Table 15: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2033

Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 17: Europe Market Value (US$ Million) Forecast by Drug Type, 2017 to 2033

Table 18: Europe Market Value (US$ Million) Forecast by Animal Type, 2017 to 2033

Table 19: Europe Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033

Table 20: Europe Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2033

Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 22: Asia Pacific Market Value (US$ Million) Forecast by Drug Type, 2017 to 2033

Table 23: Asia Pacific Market Value (US$ Million) Forecast by Animal Type, 2017 to 2033

Table 24: Asia Pacific Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033

Table 25: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2033

Table 26: MEA Market Value (US$ Million) Forecast by Country, 2017 to 2033

Table 27: MEA Market Value (US$ Million) Forecast by Drug Type, 2017 to 2033

Table 28: MEA Market Value (US$ Million) Forecast by Animal Type, 2017 to 2033

Table 29: MEA Market Value (US$ Million) Forecast by Route of Administration, 2017 to 2033

Table 30: MEA Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Animal Type, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 6: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 9: Global Market Value (US$ Million) Analysis by Drug Type, 2017 to 2033

Figure 10: Global Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 11: Global Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 12: Global Market Value (US$ Million) Analysis by Animal Type, 2017 to 2033

Figure 13: Global Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033

Figure 14: Global Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033

Figure 15: Global Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033

Figure 16: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 17: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 18: Global Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2033

Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 21: Global Market Attractiveness by Drug Type, 2023 to 2033

Figure 22: Global Market Attractiveness by Animal Type, 2023 to 2033

Figure 23: Global Market Attractiveness by Route of Administration, 2023 to 2033

Figure 24: Global Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 25: Global Market Attractiveness by Region, 2023 to 2033

Figure 26: North America Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 27: North America Market Value (US$ Million) by Animal Type, 2023 to 2033

Figure 28: North America Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 29: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 34: North America Market Value (US$ Million) Analysis by Drug Type, 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 37: North America Market Value (US$ Million) Analysis by Animal Type, 2017 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033

Figure 40: North America Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033

Figure 41: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 42: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 43: North America Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2033

Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 46: North America Market Attractiveness by Drug Type, 2023 to 2033

Figure 47: North America Market Attractiveness by Animal Type, 2023 to 2033

Figure 48: North America Market Attractiveness by Route of Administration, 2023 to 2033

Figure 49: North America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 50: North America Market Attractiveness by Country, 2023 to 2033

Figure 51: Latin America Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 52: Latin America Market Value (US$ Million) by Animal Type, 2023 to 2033

Figure 53: Latin America Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 54: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 59: Latin America Market Value (US$ Million) Analysis by Drug Type, 2017 to 2033

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 62: Latin America Market Value (US$ Million) Analysis by Animal Type, 2017 to 2033

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033

Figure 65: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 68: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2033

Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 71: Latin America Market Attractiveness by Drug Type, 2023 to 2033

Figure 72: Latin America Market Attractiveness by Animal Type, 2023 to 2033

Figure 73: Latin America Market Attractiveness by Route of Administration, 2023 to 2033

Figure 74: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 76: Europe Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 77: Europe Market Value (US$ Million) by Animal Type, 2023 to 2033

Figure 78: Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 79: Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 84: Europe Market Value (US$ Million) Analysis by Drug Type, 2017 to 2033

Figure 85: Europe Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 86: Europe Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 87: Europe Market Value (US$ Million) Analysis by Animal Type, 2017 to 2033

Figure 88: Europe Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033

Figure 89: Europe Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033

Figure 90: Europe Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033

Figure 91: Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 92: Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 93: Europe Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2033

Figure 94: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 95: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 96: Europe Market Attractiveness by Drug Type, 2023 to 2033

Figure 97: Europe Market Attractiveness by Animal Type, 2023 to 2033

Figure 98: Europe Market Attractiveness by Route of Administration, 2023 to 2033

Figure 99: Europe Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 100: Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: Asia Pacific Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 102: Asia Pacific Market Value (US$ Million) by Animal Type, 2023 to 2033

Figure 103: Asia Pacific Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 104: Asia Pacific Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Drug Type, 2017 to 2033

Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Animal Type, 2017 to 2033

Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033

Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033

Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033

Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 118: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2033

Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 121: Asia Pacific Market Attractiveness by Drug Type, 2023 to 2033

Figure 122: Asia Pacific Market Attractiveness by Animal Type, 2023 to 2033

Figure 123: Asia Pacific Market Attractiveness by Route of Administration, 2023 to 2033

Figure 124: Asia Pacific Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 125: Asia Pacific Market Attractiveness by Country, 2023 to 2033

Figure 126: MEA Market Value (US$ Million) by Drug Type, 2023 to 2033

Figure 127: MEA Market Value (US$ Million) by Animal Type, 2023 to 2033

Figure 128: MEA Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 129: MEA Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 130: MEA Market Value (US$ Million) by Country, 2023 to 2033

Figure 131: MEA Market Value (US$ Million) Analysis by Country, 2017 to 2033

Figure 132: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: MEA Market Value (US$ Million) Analysis by Drug Type, 2017 to 2033

Figure 135: MEA Market Value Share (%) and BPS Analysis by Drug Type, 2023 to 2033

Figure 136: MEA Market Y-o-Y Growth (%) Projections by Drug Type, 2023 to 2033

Figure 137: MEA Market Value (US$ Million) Analysis by Animal Type, 2017 to 2033

Figure 138: MEA Market Value Share (%) and BPS Analysis by Animal Type, 2023 to 2033

Figure 139: MEA Market Y-o-Y Growth (%) Projections by Animal Type, 2023 to 2033

Figure 140: MEA Market Value (US$ Million) Analysis by Route of Administration, 2017 to 2033

Figure 141: MEA Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 142: MEA Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 143: MEA Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2033

Figure 144: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 145: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 146: MEA Market Attractiveness by Drug Type, 2023 to 2033

Figure 147: MEA Market Attractiveness by Animal Type, 2023 to 2033

Figure 148: MEA Market Attractiveness by Route of Administration, 2023 to 2033

Figure 149: MEA Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 150: MEA Market Attractiveness by Country, 2023 to 2033

Recommendations

Healthcare

Companion Animal Drugs Market

Published : February 2023

Explore Healthcare Insights

View Reports